EPO revokes another Novo Nordisk patent covering Ozempic and Wegovy
The appeal board went against its preliminary opinion. JUVE Patent says generic semaglutide could reach Europe as early as 2031 instead of 2037.
Recap by typeshit. Full story at JUVE Patent.